This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Cubist Pharmaceuticals Inc (CBST)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 91.06M 104.04M 197.62M 372.97M
Receivables 123.16M 93.47M 87.80M 61.20M
Inventories 57.66M 41.95M 34.89M 23.82M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 869.77M 1.16B 1.04B 1.02B
Property, Plant & Equipment, Gross 255.50M 229.99M 225.58M 138.68M
Accumulated Depreciation & Depletion 77.96M 63.53M 57.16M 56.25M
Property, Plant & Equipment, Net 177.54M 166.46M 168.42M 82.43M
Intangibles 721.07M 152.83M 174.98M 207.84M
Other Non-Current Assets 994.42M 341.91M 378.64M 47.18M
Total Non-Current Assets 2.28B 775.34M 844.18M 398.91M
Liabilities & Shareholder Equity
Total Assets 3.15B 1.93B 1.89B 1.42B
Accounts Payable 31.88M 45.60M 32.58M 23.48M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 27.46M 42.50M 71.00M 30.99M
Total Current Liabilities 310.83M 258.52M 252.38M 150.64M
Long Term Debt 817.83M 367.81M 454.25M 435.80M
Deferred Income Taxes 357.80M 103.08M 143.18M 82.83M
Other Non-Current Liabilities 265.63M 212.23M 237.79M 82.46M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.44B 683.12M 835.21M 601.09M
Total Liabilities 1.75B 941.64M 1.09B 751.73M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.39B 990.75M 799.86M 663.42M
Common Par 74.00K 65.00K 63.00K 59.00K
Additional Paid In Capital 1.36B 940.97M 904.28M 800.62M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 31.20M 49.77M -104.30M -137.32M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 215.00K -59.00K -185.00K 71.00K
Total Capitalization 2.21B 1.36B 1.25B 1.10B
Total Equity 1.39B 990.75M 799.86M 663.42M
Total Liabilities & Stock Equity 3.15B 1.93B 1.89B 1.42B
Total Common Shares Outstanding 74.43M 64.71M 62.64M 59.34M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 68.16M 63.77M 60.84M 58.80M
Diluted Weighted Shares Outstanding 68.16M 81.44M 62.94M 62.66M
Number of Employees 873 762 669 638
Number of Part-Time Employees 0 0 0 0
CBST News

CBST Cubist Pharmaceuticals Inc

Analysts Ratings for CBST

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 6 6
Moderate Buy 1 1 1 1
Hold 5 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
GET CBST ANALYST REPORT

Brokerage Partners

CBST Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs